Description
This blend combines 5 mg CJC-1295 and 5 mg ipamorelin per vial. CJC-1295 belongs to the growth-hormone-releasing-hormone analogue class, while ipamorelin is a ghrelin-receptor agonist studied in growth-hormone signaling. Ingredient literature provides pathway background, not proof of the finished blend’s effects. Confirm the CJC component’s DAC status in batch documentation before selecting a research protocol.
US manufactured. For laboratory research only. Not for human or veterinary use.
